Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China Ministries Establish System To Crack Down On Counterfeit Drugs

This article was originally published in PharmAsia News

Executive Summary

To coordinate the crack-down on counterfeit drug production and sales, China's Ministry of Health, State FDA and 11 relevant ministries will be setting up an inter-ministerial joint conference system. The headquarters for the meeting will be based at SFDA, with the heads of MOH and SFDA respectively acting as convener and deputy convener. When established, the system will conduct a special one-year program to: (1) tighten control of the Internet to arrest the online counterfeit drug trade; (2) bust fake drug sales transacted via express post; (3) strengthen supervision on drug advertisements; (4) standardize drug purchase of healthcare institutions; (5) improve relevant laws and regulations; and (6) launch patient education to promote basic healthcare knowledge. (Click here for more - Chinese Language)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC071720

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel